Physician

Maria Rappai, M.D.

According to 2025 Medicare claims, Maria Rappai, M.D. (NPI: 1972597961) practices pulmonary disease in the Jackson, MS market, with the plurality of this provider's patient population coming from Hinds, MS. This provider's primary affiliated billing organization is JACKSON PULMONARY ASSOCIATES, PA (NPI: 1174570584; TIN: 64-0735747) and primary practice location at 39202-2064. Rappai is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rappai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,523 traditional Medicare patients, billed 9,430 HCPCS/CPT codes, and received $687,450 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,307 prescription claims across 639 beneficiaries totaling $3,955,635 in drug costs, led by Tyvaso Dpi (Treprostinil). DME data shows 10,295 claims. Open Payments data shows 69 records totaling $5,469. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $524,425 to $687,450. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,847,633 to $3,955,635. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $492,459 and ending at $676,444.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,243	6,644	$524,425
2016	1,285	7,142	$514,981
2017	1,285	7,691	$622,735
2018	1,342	8,690	$716,919
2019	1,408	9,641	$801,132
2020	1,376	10,236	$935,049
2021	1,277	9,050	$770,241
2022	1,425	9,883	$807,830
2023	1,595	10,464	$835,737
2024	1,523	9,430	$687,450

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	508	3,236	$1,847,633
2016	501	3,373	$1,660,488
2017	550	3,354	$2,001,009
2018	544	3,241	$1,932,782
2019	582	3,604	$3,274,474
2020	634	3,602	$3,861,101
2021	631	3,684	$3,452,462
2022	643	3,734	$4,058,781
2023	639	3,438	$3,893,314
2024	639	3,307	$3,955,635

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,392	6,219	$537,510
2016	2,985	7,407	$552,768
2017	3,599	9,011	$622,334
2018	4,111	9,548	$746,683
2019	3,947	9,342	$783,072
2020	4,033	9,242	$514,942
2021	4,349	9,866	$622,775
2022	4,864	11,232	$770,962
2023	4,738	11,333	$740,844
2024	4,284	10,295	$674,062

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	485	618	$89
94726	Test to determine lung volumes using sensors	425	551	$37
94729	Test to examine how well the lungs exchange gases	442	578	$37
94010	Test to measure expiratory airflow and volume	475	686	$18
71046	X-ray of chest, 2 views	451	642	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tyvaso Dpi	Treprostinil	30	840	$746,037
Uptravi	Selexipag	38	1,140	$714,553
Ofev	Nintedanib Esylate	53	1,590	$642,648
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	453	16,320	$344,077
Ambrisentan	Ambrisentan	51	1,710	$332,232

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	26	260	$224,154
E0601	Continuous positive airway pressure (cpap) device	Y	399	2,186	$69,131
A7030	Full face mask used with positive airway pressure device, each	N	243	473	$42,212
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	396	778	$40,795
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	501	948	$35,384

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$5,469	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maria Rappai, M.D.?

Tedicare shows public-source Medicare data for Maria Rappai, M.D. (NPI 1972597961), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maria Rappai, M.D. have ACO affiliation data?

Maria Rappai, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Maria Rappai, M.D.?

Maria Rappai, M.D. is linked to JACKSON PULMONARY ASSOCIATES, PA (billing NPI 1174570584) in the available physician profile data.

Does Maria Rappai, M.D. have Open Payments data?

Maria Rappai, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.